Differential expression of VEGF-A mRNA by 17beta-estradiol in breast tumor cells lacking classical ER-alpha may be mediated through a variant form of ER-alpha.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Molecular and Cellular Biochemistry

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 15532726
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The role of vascular endothelial growth factor in pathological angiogenesis

  2004cited by this paper
• VEGF: A modifier of the del22q11 (DiGeorge) syndrome?

  2003cited by this paper
• Estradiol-induced vascular endothelial growth factor-A expression in breast tumor cells is biphasic and regulated by estrogen receptor-alpha dependent pathway.

  2003cited by this paper
• The biology of VEGF and its receptors

  2003cited by this paper
• Mechanism of AP-1-mediated gene expression by select organochlorines through the p38 MAPK pathway.

  2003cited by this paper
• 17alpha-estradiol-induced VEGF-A expression in rat pituitary tumor cells is mediated through ER independent but PI3K-Akt dependent signaling pathway.

  2003cited by this paper
• In vitro regulation of vascular endothelial growth factor by estrogens and antiestrogens in estrogen-receptor positive breast cancer

  2002cited by this paper
• Upstream Open Reading Frames Regulate the Translation of the Multiple mRNA Variants of the Estrogen Receptor α*

  2002cited by this paper
• Vascular endothelial growth factor: acting as an autocrine growth factor for human gastric adenocarcinoma cell MGC803.

  2001cited by this paper
• Akt activation by estrogen in estrogen receptor-negative breast cancer cells.

  2001cited by this paper
• Low pO2 and β-Estradiol Induce VEGF in MCF-7 and MCF-7-5C Cells: Relationship to in vivo Hypoxia

  2001cited by this paper
• Estrogen receptors: orchestrators of pleiotropic cellular responses

  2001cited by this paper
• Vascular endothelial growth factor is an autocrine survival factor for neuropilin-expressing breast carcinoma cells.

  2001cited by this paper
• Minireview: genomic organization of the human ERalpha gene promoter region.

  2001cited by this paper
• Estrogen targets genes involved in protein processing, calcium homeostasis, and Wnt signaling in the mouse uterus independent of estrogen receptor-alpha and -beta.

  2000cited by this paper
• Induction of p21WAF1 expression via Sp1-binding sites by tamoxifen in estrogen receptor-negative lung cancer cells

  2000cited by this paper
• Inhibition of mitogen-activated protein kinase and phosphatidylinositol 3-kinase activity in MCF-7 cells prevents estrogen-induced mitogenesis.

  2000cited by this paper
• Regulation of vascular endothelial growth factor (VEGF) gene transcription by estrogen receptors alpha and beta.

  2000cited by this paper
• Identification of functional estrogen response elements in the gene coding for the potent angiogenic factor vascular endothelial growth factor.

  2000cited by this paper
• Phosphatidylinositol 3‐kinase mediates neuroprotection by estrogen in cultured cortical neurons

  2000cited by this paper
• Tumor Angiogenesis in Chronic Pancreatitis and Pancreatic Adenocarcinoma: Impact of K-ras Mutations

  2000cited by this paper
• Estrogen-Induced Activation of the Mitogen-Activated Protein Kinase Cascade in the Cerebral Cortex of Estrogen Receptor-α Knock-Out Mice

  2000cited by this paper
• Effects of estrogen on global gene expression: identification of novel targets of estrogen action.

  2000cited by this paper
• Vascular endothelial growth factor in the rat pituitary: differential distribution and regulation by estrogen.

  2000cited by this paper
• Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase

  2000cited by this paper
• VEGF145, a Secreted Vascular Endothelial Growth Factor Isoform That Binds to Extracellular Matrix*

  1997cited by this paper
• Over expression of vascular endothelial growth factor and its receptor during the development of estrogen-induced rat pituitary tumors may mediate estrogen-initiated tumor angiogenesis.

  1997cited by this paper
• Regulation of the human retinoic acid receptor alpha gene in the estrogen receptor negative human breast carcinoma cell lines SKBR-3 and MDA-MB-435.

  1996cited by this paper
• Estrogen target tissue determines alternative promoter utilization of the human estrogen receptor gene in osteoblasts and tumor cell lines.

  1995cited by this paper
• Quantitative analysis of the transcriptional start sites of estrogen receptor in breast carcinoma.

  1995cited by this paper
• Differential expression of wild-type and variant ER mRNAs by stocks of MCF-7 breast cancer cells may account for differences in estrogen responsiveness.

  1995cited by this paper
• Retinoid-resistant estrogen receptor-negative human breast carcinoma cells transfected with retinoic acid receptor-alpha acquire sensitivity to growth inhibition by retinoids.

  1994cited by this paper
• Investigation of a new pure antiestrogen (ICI 182780) in women with primary breast cancer.

  1994cited by this paper
• Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression.

  1994cited by this paper
• Effects of 4-hydroxytamoxifen and a novel pure antioestrogen (ICI 182780) on the clonogenic growth of human breast cancer cells in vitro.

  1994cited by this paper
• Vascular endothelial growth factor/vascular permeability factor expression in the rat uterus: rapid stimulation by estrogen correlates with estrogen-induced increases in uterine capillary permeability and growth.

  1993cited by this paper
• Estradiol induction of retinoic acid receptors in human breast cancer cells.

  1993cited by this paper
• Retinoic acid resistance of estradiol-independent breast cancer cells coincides with diminished retinoic acid receptor function.

  1993cited by this paper
• The concentration of estrogen receptors in rabbit uterine myocytes decreases in culture.

  1992cited by this paper
• Molecular and biological properties of the vascular endothelial growth factor family of proteins.

  1992cited by this paper
• The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing.

  1991cited by this paper
• Interaction of retinoids and tamoxifen on the inhibition of human mammary carcinoma cell proliferation.

  1987cited by this paper
• A simple method to determine whole cell uptake of radiolabelled oestrogen and progesterone and their subcellular localization in breast cancer cell lines in monolayer culture.

  1984cited by this paper
• The specificity of the estrogen receptor of human uterus.

  1973cited by this paper
• Estimation of the association constant of the estrogen-receptor complex in human breast cancer.

  1973cited by this paper
• The influence of synthetic anti-estrogens on the binding of tritiated estradiol-17beta by cytosols of human uterus and human breast carcinoma.

  1973cited by this paper

• Transcriptional regulation of VEGF expression by estrogen-related receptor γ

  2013cites this paper
• Pomegranate sensitizes Tamoxifen action in ER-α positive breast cancer cells

  2011cites this paper
• Activation of Estrogen-Responsive Genes Does Not Require Their Nuclear Co-Localization

  2010cites this paper
• The Effects of Anthropometry and Angiogenesis on Breast Cancer Etiology

  2008cites this paper
• WISP-2/CCN5 is involved as a novel signaling intermediate in phorbol ester-protein kinase Calpha-mediated breast tumor cell proliferation.

  2006cites this paper
• Breast cancer cells secreted platelet‐derived growth factor‐induced motility of vascular smooth muscle cells is mediated through neuropilin‐1

  2006cites this paper
• Epidermal Growth Factor Induces WISP-2/CCN5 Expression in Estrogen Receptor-α-Positive Breast Tumor Cells through Multiple Molecular Cross-talks

  2005cites this paper